Skip to content

In the BioHarmony Drug Report Database

Efmoroctocog alfa

Eloctate, Elocta (efmoroctocog alfa) is a fusion protein pharmaceutical. Efmoroctocog alfa was first approved as Eloctate on 2015-11-18. It has been approved in Europe to treat hemophilia a.
Trade Name Elocta
Common Name Efmoroctocog alfa
Indication hemophilia a
Drug Class Fc fusion protein
Efmoroctocog alfa
Get full access now